Cleared Traditional

AcuityDR 1013 G4, AcuityDR 1417 G4, AcuityDR 1717G4 (K231709) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
30d
Days
Class 2
Risk

K231709 is an FDA 510(k) clearance for the AcuityDR 1013 G4, AcuityDR 1417 G4, AcuityDR 1717G4. Classified as Solid State X-ray Imager (flat Panel/digital Imager) (product code MQB), Class II - Special Controls.

Submitted by Radmedix, LLC (Dayton, US). The FDA issued a Cleared decision on July 12, 2023 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1680 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Radmedix, LLC devices

Submission Details

510(k) Number K231709 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 12, 2023
Decision Date July 12, 2023
Days to Decision 30 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 107d · This submission: 30d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQB Solid State X-ray Imager (flat Panel/digital Imager)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1680
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Kamm & Associates
Daniel Kamm

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MQB Solid State X-ray Imager (flat Panel/digital Imager)

All 146
Devices cleared under the same product code (MQB) and FDA review panel - the closest regulatory comparables to K231709.
MasterX 800 Series
K230918 · Medicatech USA · Sep 2023
YosemiteView 4343W/YosemiteView 3643W
K232058 · Careray Digital Medical Technology Co., Ltd. · Aug 2023
EXPD 4357
K231959 · DRTECH Corporation · Aug 2023
1417WCE, 1417WCE-HR, 1417WCE-HS, 1417WCE-GF
K231467 · Rayence Co., Ltd. · Jun 2023
A1417MCW/A1717MCW/F1417MCW
K223930 · H&abyz Co., Ltd. · Mar 2023
Digital Radiography CXDI-CS01
K230175 · Canon, Inc. · Feb 2023